Praxis Precision Medicines, Inc. PRAX Ratios & Valuation
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Returns | ||||||
| Return on equity | -35.3%+10.5pp | -45.8%+29.4pp | -75.2%-14.2pp | -61%+2.6pp | -63.6%+7.4pp | |
| Return on invested capital | -62.2%+24.6pp | -86.8%— | —— | —— | —— | |
| Liquidity | ||||||
| Current ratio | 15.9×+5.7× | 10.2×+5.0× | 5.2×-1.1× | 6.3×-2.1× | 8.4×-2.3× | |
| Leverage | ||||||
| Debt-to-equity | 0×0.0× | 0×0.0× | 0×0.0× | 0×0.0× | 0×0.0× | |
| Per Share | ||||||
| Book value per share | $48.82+25.1% | $39.02+150% | $15.63-17.0% | $18.82-9.8% | $20.86-16.1% | |
| Valuation | ||||||
| Market capitalization | $8.97B+21.7% | $7.37B+561% | $1.12B+24.6% | $895.42M+17.3% | $763.58M-46.8% | |
| Price / book | 6.4×-2.0× | 8.4×+5.1× | 3.2×+1.0× | 2.2×+0.5× | 1.7×-1.5× |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where do Praxis Precision Medicines, Inc.'s ratios come from?
- Every ratio is computed from Praxis Precision Medicines, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.